静脉注射铁治疗心力衰竭,缺铁的定义和临床反应:IRONMAN试验
John G F Cleland1, Philip A Kalra2,3, Pierpaolo Pellicori1
1School of Cardiovascular and Metabolic Health, University of Glasgow, 126 University Place, Glasgow, Lanarkshire, G12 8TA, UK.
European heart journal
|March 6, 2024
概括
静脉注射铁可能有利于心力衰竭患者贫血或低转林和 (TSAT). 较低的TSAT和费里丁水平与更大的血红蛋白增加以及铁治疗改善的生活质量相关.
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
- 临床试验 临床试验
背景情况:
- 铁缺乏症在心力衰竭患者中很常见.
- 缺铁性贫血可以加剧心力衰竭症状和预后.
- 静脉注射铁是一种潜在的治疗策略.
研究的目的:
- 为了研究铁缺乏症血液测试与心力衰竭患者静脉注射铁的反应之间的关系.
- 确定可能从静脉注射铁疗法中受益最多的患者子组.
主要方法:
- 在IRONMAN试验中,有1137名心力衰竭患者被随机分配给静脉注射铁甲醇 (FDI) 或常规护理.
- 评估了基线铁状况 (费里丁,TSAT) 和贫血严重程度.
- 结果包括血红蛋白的变化,生活质量 (MLwHF得分),6分钟的步行距离和临床事件.
主要成果:
- 随着FDI的增加,在患者中观察到更高的血红蛋白增加,患者的TSAT,费里丁水平较低,以及更严重的贫血.
- 在更多的贫血患者中,FDI改善了MLwHF得分.
- 缺乏贫血或TSAT ≥20%与较低的事件率和最小的外国直接投资利益有关.
结论:
- 贫血或TSAT<20%与费里丁>100μg/L可能会识别心力衰竭患者谁从静脉注射铁更受益.
- 这种产生假设的分析需要进一步确认.
相关概念视频
Exercise and Cardiovascular Response
808
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
808
Heart Failure Drugs: Inotropic Agents
586
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
586


